Format

Send to

Choose Destination
Eur Respir J. 2018 Jan 25;51(1). pii: 1702110. doi: 10.1183/13993003.02110-2017. Print 2018 Jan.

Both moderate and severe exacerbations accelerate physical activity decline in COPD patients.

Author information

1
KU Leuven, Dept of Rehabilitation Sciences, Leuven, Belgium.
2
ISGlobal, Center for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
3
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
4
CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
5
University Hospitals Leuven, Dept of Respiratory Diseases, Leuven, Belgium.
6
Both authors contributed equally.
7
Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
8
Faculty of Physical Education and Sports Sciences, National and Kapodistrian University of Athens, Athens, Greece.
9
Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Pneumology Dept, Barcelona, Spain.
10
GlaxoSmithKline, Uxbridge, UK.
11
ELEGI/Colt Laboratory, UoE/MRC Centre for Inflammation Research, The University of Edinburgh, Edinburgh, UK.
12
GRIAC-Primary Care, Dept of General Practice and Elderly Care, University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
13
Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
14
Royal Brompton and Harefield NHS Foundation Trust and Imperial College, NIHR Respiratory Biomedical Research Unit, London, UK.
15
AstraZeneca, Gothenburg, Sweden.
16
Dept of Sport, Exercise and Rehabilitation, Faculty of Health and Life Sciences, Northumbria University, Newcastle, UK.
17
ISGlobal, Center for Research in Environmental Epidemiology (CREAL), Barcelona, Spain Judith.garcia@isglobal.org.

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center